Direkt zum Inhalt
Merck

Illustrative cases of unorthodox tinnitus management.

Noise & health (2013-04-11)
Kenneth H Brookler
ZUSAMMENFASSUNG

Bone remodeling disorders have been identified as potential candidates for the etiology underlying some forms of otologic disease. Here, four clinical cases are presented to demonstrate a novel approach to tinnitus management that focuses on two fundamental etiologic bases. First, is the effect of bone remodeling abnormalities of the otic capsule and second, the effect of blood sugar and insulin abnormalities upon the function of the inner ear and self-reports of tinnitus. This report presents the effect of treatment directed at bone remodeling abnormalities of the otic capsule and abnormalities of blood sugar and insulin. The treatment effects led to a substantial reduction in subjective tinnitus. These findings suggest a potential convergence between bone pathophysiology and some forms of tinnitus.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumfluorid, ACS reagent, ≥99%
Sigma-Aldrich
Natriumfluorid, ReagentPlus®, ≥99%
Sigma-Aldrich
Natriumfluorid, 99.99% trace metals basis
Sigma-Aldrich
Natriumfluorid, anhydrous, powder, 99.99% trace metals basis
Sigma-Aldrich
Natriumfluorid, puriss., meets analytical specification of Ph. Eur., BP, USP, 98.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
Natriumfluorid, BioXtra, ≥99%
Sigma-Aldrich
Natriumfluoridlösung
Sigma-Aldrich
Natriumfluorid, BioReagent, suitable for insect cell culture, ≥99%
Sigma-Aldrich
Natriumfluorid 0,5 M -Lösung
Supelco
Fluorid-Ionenlösung für ISE, 0.1 M F-, analytical standard (for ion-selective electrodes)